It has also been reported to promote cellular proliferation in the head and neck and multiple myeloma cell lines via c-Myc and NF-κB, respectively, following TLR3 ligand poly(I:C) stimulation (17). The gene discussed is NFKB1; the disease is plasma cell myeloma.